Dynamics of urinary chloride and sodium and their link to decongestion in acute heart failure and preserved ejection fraction: NACLOCRo-HF study.
Jorge Campos, Pau Llàcer, François Croset...
https://pubmed.ncbi.nlm.nih.gov/41078081/Actively Recruiting
Led by Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · Updated on 2026-09-28
223
Participants Needed
4
Research Sites
N/A
Total Duration
Researchers are investigating how changes in urinary sodium and chloride levels relate to fluid overload and short-term outcomes in patients hospitalized with acute heart failure AHF. The study aims to determine if these changes reflect how effectively excess fluid is removed during hospital stays and whether they are linked to congestion at discharge and the risk of worsening heart failure or death afterward. This prospective, multicenter observational study plans to enroll at least 223 patients with AHF treated with intravenous diuretics. Participants hospitalized for AHF and receiving intravenous diuretics as part of their usual care will undergo multiple clinical assessments, blood and urine tests, and echocardiographic evaluations during their hospital stay. Researchers will collect biochemical and echocardiographic data, including biomarkers such as NT-proBNP, CA125, sST2, bioADM, and CD146. Clinical events like worsening heart failure and all-cause mortality will be tracked at 30 days and 3 months after discharge. Decongestion will be assessed using clinical evaluations, echographic parameters, and estimated plasma volume status. Throughout the study, participants will have repeated tests and assessments during hospitalization to monitor fluid status and heart function. Researchers will measure residual congestion 72 hours after admission and follow participants for clinical outcomes for up to three months after discharge. The study focuses on evaluating how urinary sodium and chloride dynamics relate to patient outcomes in AHF without interfering with standard treatments, lasting from hospital admission through three months post-discharge.
CONDITIONS
Urinary Chloride and Sodium Changes and Residual Congestion in Acute Heart Failure
P
Pau Llàcer Iborra, MD PhD
C
Cristina Fernández Soler
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Lead Sponsor
Carlos III Health Institute
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Duration of hospital stay
Participants receive usual care for acute heart failure with intravenous diuretics. Clinical assessments, blood and urine tests, and echocardiographic evaluations are performed at multiple time points during the hospital stay to track fluid status and heart function.
Multiple assessments during hospitalization
Duration - 3 months after discharge
Researchers monitor participants' clinical outcomes, including worsening heart failure and all-cause mortality, at 30 days and 3 months after hospital discharge to evaluate short-term effects.
2 follow-up assessments
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Jorge Campos, Pau Llàcer, François Croset...
https://pubmed.ncbi.nlm.nih.gov/41078081/Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Lead Sponsor
Carlos III Health Institute
Collaborating Sponsor